Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Attack of the Mutants

Posted on March 3rd, 2016 by


lungs, disease

Most parents know how difficult it is to prevent children from taking up bad or unhealthy habits. Children tend to ignore their parents’ advice, convinced as they are that nothing will ever happen to them or their parents are making a fuss about nothing. Continue reading “Attack of the Mutants” »

Validation: The importance of search formulas in Literature Monitoring

Posted on February 29th, 2016 by



A reasonable number of Market Authorization Holders (MAHs) have no ready answer to justify why they use a specific search formula for each specific product when Audit or Inspection time comes: Continue reading “Validation: The importance of search formulas in Literature Monitoring” »

Small Steps with Giant Impact in Pre-Clinical Research

Posted on February 19th, 2016 by

Pharma R&D


In my last blog entry, I briefly touched up on the various reasons to share your data: it can only make your research better, and help inform the researchers who are doing similar work – or building on what you’ve done. Continue reading “Small Steps with Giant Impact in Pre-Clinical Research” »

Of People with Ideas: Strengthening an ecosystem of innovation

Posted on February 18th, 2016 by

Pharma R&D


In the last three decades, the pharmaceutical industry has undergone a transformation unprecedented in the nearly 100-year history of prescription drugs. Continue reading “Of People with Ideas: Strengthening an ecosystem of innovation” »

Go Inside the Mind of a Chemist

Posted on February 16th, 2016 by


magnifying glass inside mind

Time is crucial to chemists. The faster they can find information, the more quickly they can innovate. Did you know that retrieving extracted data is faster than finding answers in full text literature? Continue reading “Go Inside the Mind of a Chemist” »

Transparency for Better Science

Posted on February 10th, 2016 by

Pharma R&D


I like to think of scientific discovery as not unlike parenthood: scientists create a piece of knowledge (like a child), and then release it to its own life in the world (a grown-up child), and, often, that piece of knowledge informs the Continue reading “Transparency for Better Science” »

  1. 1
  2. …
  3. 53
  4. 54
  5. 55
  6. 56
  7. 57
  8. …
  9. 61

About this Blog


The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.